Suppr超能文献

腺苷输注试验在重复房颤消融中的临床应用。

Clinical utility of adenosine-infusion test at a repeat atrial fibrillation ablation procedure.

机构信息

Cardiovascular Center, Tsuchiura Kyodo Hospital, Ibaraki, Japan.

出版信息

Heart Rhythm. 2013 May;10(5):629-35. doi: 10.1016/j.hrthm.2012.12.032. Epub 2012 Dec 31.

Abstract

BACKGROUND

The majority of patients with recurrence of arrhythmia after the initial atrial fibrillation (AF) ablation procedure have resumption of pulmonary vein (PV) conduction. Adenosine-infusion test after PV isolation identifies acute dormant PV conduction during the index procedure.

OBJECTIVE

To evaluate the utility of adenosine-infusion test at a repeat AF ablation procedure.

METHODS

This study included 50 consecutive patients (38 men; mean age 65 ± 9 years) who underwent second ablation procedure for recurrent atrial tachyarrhythmia(s). At the index procedure, which was undertaken for paroxysmal AF, all patients underwent PV isolation and 48 of 50 (96%) underwent superior vena cava (SVC) isolation followed by adenosine infusion. PV and SVC were reisolated-if found reconnected-at the start of the second procedure. Thereafter, adenosine-infusion test was undertaken for all PVs in all patients.

RESULTS

At the index procedure, adenosine infusion revealed dormant PV conduction in 15 of 50 (30%) patients. At the second procedure, after 10 ± 10 months, PV and SVC reconnections were observed in 46 of 50 (92%) and 33 of 48 (68.8%) patients and they were reisolated. Subsequently, adenosine-infusion test revealed dormant PV conduction in 9 of 50 (18%) patients, including 3 of 50 (6%) who had no PV reconnection at the start of the procedure. In these 3 patients, transient AF resulted after adenosine infusion, and at mean 8.0 ± 3.4 months, they were free from any atrial arrhythmia after the elimination of dormant PV conduction alone.

CONCLUSIONS

Adenosine-infusion test reveals dormant thoracic vein conduction associated with arrhythmia recurrence in the chronic phase after the initial PV isolation.

摘要

背景

大多数初始心房颤动(AF)消融术后心律失常复发的患者均恢复了肺静脉(PV)传导。PV 隔离后腺苷输注试验可在指数程序中识别急性潜伏 PV 传导。

目的

评估腺苷输注试验在重复 AF 消融术中的效用。

方法

本研究纳入了 50 例连续患者(38 例男性;平均年龄 65 ± 9 岁),他们因复发性房性心动过速(心律失常)而接受了第二次消融手术。在初始手术中,对于阵发性 AF,所有患者均进行了 PV 隔离,50 例中的 48 例(96%)进行了上腔静脉(SVC)隔离,然后进行了腺苷输注。如果在第二次手术开始时发现重新连接,则重新隔离 PV 和 SVC。此后,对所有患者的所有 PV 进行了腺苷输注试验。

结果

在初始手术中,腺苷输注显示 50 例中的 15 例(30%)存在潜伏 PV 传导。在第二次手术中,10 ± 10 个月后,在 50 例中的 46 例(92%)和 48 例中的 33 例(68.8%)中观察到 PV 和 SVC 重新连接,并对其进行了重新隔离。随后,在 50 例中的 9 例(18%)患者中发现了潜伏的 PV 传导,其中 50 例中有 3 例(6%)在手术开始时没有 PV 重新连接。在这 3 例患者中,腺苷输注后出现短暂性 AF,在平均 8.0 ± 3.4 个月后,单独消除潜伏的 PV 传导后,他们不再出现任何房性心律失常。

结论

腺苷输注试验可揭示初始 PV 隔离后慢性期与心律失常复发相关的潜伏胸静脉传导。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验